PMID: 11922400Apr 2, 2002Paper

Atorvastatin plus pravastatin for the treatment of heterozygous familial hypercholesterolaemia--a pilot study

Current Medical Research and Opinion
V G AthyrosA G Kontopoulos

Abstract

The most common side-effect of statins, mainly during dose titration, is liver toxicity, In these cases, sufficient control of low density lipoprotein cholesterol (LDL-C) in patients with heterozygous familial hypercholesterolaemia (HFH) becomes problematical. In patients with intolerance to resins as well, especially in the presence of coronary artery disease (CAD), it is practically impossible to reach the LDL-C treatment goal. This study included seven HFH patients with CAD, who presented with alanine amino transferase levels greater than three times the upper normal limit during dose titration of atorvastatin or simvastatin of from 20 mg/day to 40 mg/day. They could not tolerate concomitant cholestyramine administration, and presented with LDL-C levels significantly higher than the treatment goal (100 mg/dl; 2.6 mmol/l). In these patients, a combination of two statins with different pharmacokinetics (20 mg/day of atorvastatin plus 40mg/day of pravastatin) was administered for a mean period of one year. Efficacy was compared with that of monotherapy with each drug alone and with that of 40 mg of atorvastatin in 13 patients, who could also not tolerate resin co-administration, and that of 40 mg/day of atorvastatin plus 12 g o...Continue Reading

References

Jun 1, 1995·Journal of Cardiovascular Risk·J Heinrich, G Assmann
Jul 21, 1999·Journal of Cardiovascular Pharmacology·B TesfamariamR E Gregg
Sep 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J A Farmer, G Torre-Amione
Nov 14, 2000·The American Journal of Cardiology·W C Cromwell, P E Ziajka
Dec 21, 2000·Current Atherosclerosis Reports·M H Davidson
Mar 20, 2001·Atherosclerosis·R S RosensonE J Schaefer
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jul 24, 2001·Current Medical Research and Opinion·D R IllingworthUNKNOWN Simvastatin Atorvastatin HDL Study Group
Jul 27, 2001·The American Journal of Cardiology·J M McKenneyM L Watkins
Aug 18, 2001·BMJ : British Medical Journal·F Charatan
Sep 12, 2001·Atherosclerosis·A KakafikaM Elisaf
Sep 26, 2001·Circulation·R SoRelle

❮ Previous
Next ❯

Citations

Jan 1, 2014·The Cochrane Database of Systematic Reviews·Layli EslamiHermineh Aramin

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.